Critical review of PET-CT for radiotherapy planning in lung cancer

Critical Reviews in Oncology/Hematology

Volumn 56, Issue 3, 2005, Pages 345-351

  Senan, Suresh ^a,c,d   De Ruysscher, Dirk ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d EORTC Lung Cancer Group   (Belgium)

Author keywords

Lung cancer; PET scans; Radiotherapy planning; Target volumes

Indexed keywords

3' FLUOROTHYMIDINE; TRACER;

ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; HUMAN; IMAGE ANALYSIS; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING;

EID: 27944463193     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2005.05.001     Document Type: Review

References (49)

1. A. Rempel, S.P. Mathupala, C.A. Griffin, A.L. Hawkins, and P.L. Pedersen Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase Cancer Res 56 1996 2468 2471
2. B.A. Dwamena, S.S. Sonnad, and J.O. Angobaldo Metastases from non-small cell lung cancer: mediastinal staging in the 1990's. Meta-analytic comparison of PET and CT Radiology 213 1999 530 536
3. V. Gregoire Is there any future in radiotherapy planning without the use of PET: unraveling the myth Radiother Oncol 73 2004 261 263
4. J.R. van Sörnsen de Koste, F.J. Lagerwaard, and M.R.J. Nijssen-Visser Which margins are necessary for incorporating mediastinal nodal mobility in involved field radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys 53 2002 115 119
5. J.R. van Sörnsen de Koste, F.J. Lagerwaard, and M.R. Nijssen-Visser Tumor location cannot predict the mobility of lung tumors: a 3D analysis of data generated from multiple CT scans Int J Radiat Oncol Biol Phys 56 2003 348 354
6. C. Plathow, S. Ley, and C. Fink Analysis of intrathoracic tumor mobility during whole breathing cycle by dynamic MRI Int J Radiat Oncol Biol Phys 59 2004 952 959
7. C.B. Caldwell, K. Mah, and C.E. Danjoux Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET Int J Radiat Oncol Biol Phys 55 2003 1381 1393
8. G.W. Goerres, C. Burger, and E. Kamel Respiration-induced attenuation artifact at PET/CT: technical considerations Radiology 226 2003 906 910
9. S. Jang, J.F. Greskovich, and B.A. Milla Effects of PET/CT image registration on radiation treatment planning in lung cancer Int J Radiat Onclol Biol Phys 57 Suppl. 2 2003 414S 415S
10. I.F. Ciernik, E. Ditzendorf, and B.G. Baumert Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study Int J Radiat Oncol Biol Phys 57 2003 853 863
11. J. Bradley, W.L. Thorstad, and S. Mutic Impact of FDG-PET on radiation therapy volume delineation in non-small cell lung cancer Int J Radiat Oncol Biol Phys 59 2004 78 86
12. J. Czernin, and H. Schelbert PET/CT imaging: facts, opinions, hopes, and questions J Nucl Med 45 1 (Suppl.) 2004 1S 3S
13. 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer J Nucl Med 42 2001 1596 1604
14. J.D. Bradley, C.A. Perez, F. Dehdashti, and B.A. Siegel Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer J Nucl Med 45 Suppl. 1 2004 96S 101S [Review]
15. R.C. Viney, M.J. Boyer, and M.T. King Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer J Clin Oncol 22 2004 2357 2362
16. R. Sasaki, R. Komaki, and H. Macapinlac [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer J Clin Oncol 23 2005 1136 1143
17. J.J. Beitler Mirror, mirror on the wall - which is the greatest predictive assay of them all? Int J Radiat Oncol Biol Phys 59 2004 1272 1273
18. S. Senan, D. De Ruysscher, P. Giraud, R. Mirimanoff, and V. Budach Literature-based recommendations for treatment planning and execution for high-precision radiotherapy in lung cancer Radiother Oncol 71 2004 139 146
19. B.M. Fischer, J. Mortensen, and L. Hojgaard Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review Lancet Oncol 2 2001 659 666
20. M.K. Gould, W.G. Kuschner, and C.E. Rydzak Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small cell lung cancer: a meta-analysis Ann Intern Med 139 2003 879 892
21. E.M. Toloza, L. Harpole, and C. McCrory Non-invasive staging of non-small cell lung cancer: a review of the current evidence Chest 123 2003 137S 146S
22. 18FDG-PET-CT planning in patients with clinical CT stage N2/N3 M0 non-small cell lung cancer (NSCLC): a modelling study Int J Radiat Oncol Biol Phys 61 2005 648 654
23. De Ruysscher D, Wanders S, van Haren E, et al. Selective mediastinal node irradiation on basis of the FDG-PET scan in patients with non-small cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys, in press.
24. P.F. Roberts, D.M. Follette, and D. von Haag Factors associated with false-positive staging of lung cancer by positron emission tomography Ann Thorac Surg 70 2000 1154 1159
25. T.P. Graeter, D. Hellwig, and K. Hoffmann Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy Ann Thorac Surg 75 2003 231 236
26. J.T. Annema, O.S. Hoekstra, and E.F. Smit Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA Lung Cancer 44 2004 53 60
27. J.F. Vansteenkiste, S.G. Stroobants, P.J. Dupont Leuven Lung Cancer Group FDG-PET scan in operable non-small cell lung cancer: do anatomometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? Eur J Nucl Med 25 1998 1495 1501
28. P. Magnani, A. Carretta, and G. Rizzo FDG/PET and spiral CT image fusion for mediastinal lymph node assessment of non-small cell lung cancer patients J Cardiovasc Surg Torino 40 1999 741 748
29. S.L. Aquino, J.C. Asmuth, and R.H. Moore Improved image interpretation with registered thoracic CT and positron emission tomography tomography data sets AJR Am J Roentgenol 348 2002 939 944
30. D. Lardinois, W. Weder, and T.F. Hany Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2003 2500 2507
31. R.J. Cerfolio, B. Ojha, and A.S. Bryant The accuracy of integrated PET-CT compared with dedicated pet alone for the staging of patients with nonsmall cell lung cancer Ann Thorac Surg 78 2004 1017 1023
32. J.F. Vansteenkiste Nodules CT-scans and PET-scans: agood partnership Lung Cancer 45 2004 19 27 [Editorial]
33. R.C. Bittner, and R. Felix Magnetic resonance (MR) imaging of the chest: state-of-the-art Eur Respir J 11 1998 1392 1404
34. A.C. Paulino, and P.A. Johnstone FDG-PET in radiotherapy treatment planning: Pandora's box? Int J Radiat Oncol Biol Phys 59 2004 4 5
35. C.B. Caldwell, K. Mah, M. Skinner, and C.E. Danjoux Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET Int J Radiat Oncol Biol Phys. 55 2003 1381 1393
36. F.J. Lagerwaard, J.R. van Sornsen de Koste, and M.R.J. Nijssen-Visser Multiple 'slow' CT scans for incorporating lung tumor mobility in radiotherapy planning Int J Radiat Oncol Biol Phys 51 2001 932 937
37. R.W.M. Underberg, F.J. Lagerwaard, and J.P. Cuijpers 4-Dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer Int J Radiat Oncol Biol Phys 60 2004 1283 1290
38. S.A. Nehmeh, Y.E. Erdi, and K.E. Rosenzweig Reduction of respiratory motion artifacts in PET imaging of lung cancer by respiratory correlated dynamic PET: methodology and comparison with respiratory gated PET J Nucl Med 44 2003 1644 1648
39. M.P. MacManus, R.J. Hicks, and J.P. Matthews Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small cell lung cancer J Clin Oncol 21 2003 1285 1292
40. Y. Ichiya, Y. Kuwabara, and M. Sasaki A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma Ann Nucl Med 10 1996 193 200
41. M.E. Hebert, V.J. Lowe, and J.M. Hoffman Positron emission tomography in the pre-treatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings Am J Clin Oncol 19 1996 416 421
42. C.M. DeYoung, M.J. Edelman, and A. Patel The ability of whole body FDG18 PET imaging to predict pathologic response to induction chemoradiotherapy in stage IIIA and IIIB non-small cell lung cancer. results of a phase I/II subanalysis Int J Radiat Oncol Biol Phys 60 Suppl. 2004 S202
43. R.J. Cerfolio, A.S. Bryant, T.S. Winokur, and B. Ohja Bartolucci AA Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer Ann Thorac Surg 78 6 2004 1903 1909
44. J. Chin, Robert, and T.W. McCain Whole body FDG-PET for the evaluation and staging of PET in limited-stage SCLC small cell lung cancer: a preliminary study Lung Cancer 37 2002 1 6
45. Y.Y. Shen, Y.C. Shiau, and J.J. Wang Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer Anticancer Res 22 2002 1257 1264
46. J.D. Bradley, F. Dehdashti, and M.A. Mintun Positron emission tomography in limited-stage small-cell lung cancer: a prospective study J Clin Oncol 22 2004 3248 3254
47. I. Brink, T. Schumacher, and M. Mix Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer Eur J Nucl Med Mol Imaging 31 2004 1614 1620
48. 18F-FDG J Nucl Med 44 2003 1426 1431
49. C.C. Ling, J. Humm, and S. Larson Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality Int J Radiat Oncol Biol Phys. 47 2000 551 560